Evidence map›Paper›PMID 42707657›Full record

ReviewFrontiers in microbiology2026

Therapeutic regulation of gut microbiota in gastric cancer: mechanisms, strategies, and clinical prospects.

Zicheng Liu, Mingyue Bai, Lichao Han, Zeguang Li

Abstract readReview
In one paragraph

Review in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zicheng LiuThe First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China.
Mingyue BaiZhuhai Hospital of the Guangdong Provincial Hospital of Traditional Chinese Medicine, Zhuhai, Guangdong, China.
Lichao HanThe First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China.
Zeguang LiThe First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer (GC) is a highly prevalent malignancy associated with substantial mortality worldwide. Dysbiosis of the gut microbiota is closely linked to the pathogenesis, clinical characteristics, and therapeutic responses of GC, making it a central focus of research in the field of tumor microecology. However, existing reviews mainly focus on microbial compositional features, individual mechanisms, or specific microbiota-based interventions, while lacking an integrated theoretical framework that incorporates

Indexed as

gastric cancergut microbiotaHelicobacter pylorimicrobiota imbalanceprobiotics

Identifiers

PMID42707657
PMCPMC13549186

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.